Roham Zamanian (@docroham) 's Twitter Profile
Roham Zamanian

@docroham

Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.

ID: 844963244

linkhttp://wallcenter.stanford.edu calendar_today25-09-2012 06:02:46

653 Tweet

1,1K Takipçi

634 Takip Edilen

Roham Zamanian (@docroham) 's Twitter Profile Photo

Second day of DIPH Symposium 2023 starts at 8 am PST. First day was amazing, 2nd will be exciting. Join us! livestream.com/accounts/19731… Or youtube.com/live/j54HG3dBT…

Second day of DIPH Symposium 2023 starts at 8 am PST.  First day was amazing, 2nd will be exciting.  Join us!

livestream.com/accounts/19731…

Or 

youtube.com/live/j54HG3dBT…
Jason Weatherald MD (@albertaphdoc) 's Twitter Profile Photo

Olivier Sitbon discusses the approach to Dasatinib-associated PAH at the Stanford University Drug Induced PH symposium 1️⃣Stop the drug! 2/3 will resolve with discontinuation alone 2️⃣Treatment based on risk/severity. Roham Zamanian Vinicio de Jesus Perez, MD FAHA FCCP ATSF @pvri

<a href="/OSitbon/">Olivier Sitbon</a> discusses the approach to Dasatinib-associated PAH at the <a href="/Stanford/">Stanford University</a> Drug Induced PH symposium

1️⃣Stop the drug! 2/3 will resolve with discontinuation alone

2️⃣Treatment based on risk/severity. 

<a href="/docroham/">Roham Zamanian</a> <a href="/Viniciodjperez/">Vinicio de Jesus Perez, MD FAHA FCCP ATSF</a> @pvri
Roham Zamanian (@docroham) 's Twitter Profile Photo

RIP Major Brian Shul! Incredible story of an aviator. - resilience, courage, and grit. Spoke at our Stanford Wall Center pulmonary hypertension symposium a few years ago…. nytimes.com/2023/05/30/us/…

Roham Zamanian (@docroham) 's Twitter Profile Photo

Difficult news to hear….a huge loss for the field and our community. On behalf of Stanford Wall Center, our deepest condolences to the Newman family and Vanderbilt colleagues. His legacy will live on thru his contributions to our field and the many he has mentored.

Roham Zamanian (@docroham) 's Twitter Profile Photo

A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective pubmed.ncbi.nlm.nih.gov/38471030/ Stanford Wall Center Jason Weatherald MD The Pulmonary Vascular Research Institute

Roham Zamanian (@docroham) 's Twitter Profile Photo

Incredible. Hats off to all scientists/investigators/patients(!). Excited to have access to therapy w such a potential. BUT!!!! Inaccurate& misleading news will NOT help our field or patients. Opinion is not fact! The Pulmonary Vascular Research Institute Vinicio de Jesus Perez, MD FAHA FCCP ATSF Jason Weatherald MD cnn.com/2024/03/26/hea…

Roham Zamanian (@docroham) 's Twitter Profile Photo

Excited to have been part of a superb Phase 2 study of Seralutinib in PAH. Read it below: sciencedirect.com/science/articl…